NCT02941016撤回4 期
Vascular Inflammation and Cholesterol Lowering Therapy
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 撤回
- 试验地点
- 1
- 主要终点
- Change in vascular inflammation
研究概览
简要总结
This study aim to detect change in vascular inflammation following intense lipid lowering therapy
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •treatment with PCSK-9 inhibitors
排除标准
- •Infection Pregnancy Severe claustrophobia Weight >140 kg
研究组 & 干预措施
Lipid lowering
Experimental
干预措施: Evolocumab or Alirocumab (Drug)
结局指标
主要结局
Change in vascular inflammation
时间窗: 12 weeks
Change in standard uptake value (SUV) of flourdeoxyglucose (FDG) before and after initiation of lipid lowering therapy
次要结局
未报告次要终点
研究者
Rasmus S. Ripa
Staff Physician
Rigshospitalet, Denmark
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Influence of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering TreatmentMyocardial Infarction [C14.907.585.500]NCT01245894Odense University Hospital87
已完成
3 期
Lipid Research Clinics Coronary Primary Prevention Trial (CPPT)Cardiovascular DiseasesCoronary DiseaseHeart DiseasesMyocardial IschemiaNCT00000488National Heart, Lung, and Blood Institute (NHLBI)
已完成
4 期
Effect of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment on Endothelial FunctionEndothelial DysfunctionAtherosclerosisNCT01223625Odense University Hospital87
已完成
4 期
Effect of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment on Carotid Intima-media Thickness (CIMT)ST-segment Elevation Myocardial InfarctionSubclinical Carotid AtherosclerosisNCT01203982Odense University Hospital87
进行中（未招募）
4 期
Effect of Intensive LDL-cholesterol Targeting for Elderly Patients With Cardiovascular Disease: I-OLD TrialCardiovascular DiseaseNCT05361421Yonsei University1,200